These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10319943

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO).
    Yin F, Giuliano AE, Van Herle AJ.
    Anticancer Res; 1999; 19(5B):4297-303. PubMed ID: 10628390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding-dependent and -independent mechanisms.
    Collins-Burow BM, Burow ME, Duong BN, McLachlan JA.
    Nutr Cancer; 2000; 38(2):229-44. PubMed ID: 11525602
    [Abstract] [Full Text] [Related]

  • 10. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML, Califano D, Baldassarre G, Celetti A, Merolla F, Forzati F, Napolitano M, Tavernise B, Fusco A, Viglietto G.
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas.
    Zeng Q, Chen G, Vlantis A, Tse G, van Hasselt C.
    J Pathol; 2008 Mar; 214(4):425-33. PubMed ID: 18085520
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Growth factor production by human thyroid carcinoma cells: abundant expression of a platelet-derived growth factor-B-like protein by a human papillary carcinoma cell line.
    Matsuo K, Tang SH, Sharifi B, Rubin SA, Schreck R, Fagin JA.
    J Clin Endocrinol Metab; 1993 Oct; 77(4):996-1004. PubMed ID: 8408476
    [Abstract] [Full Text] [Related]

  • 20. Treatment of aggressive thyroid cancer with an oncolytic herpes virus.
    Yu Z, Eisenberg DP, Singh B, Shah JP, Fong Y, Wong RJ.
    Int J Cancer; 2004 Nov 10; 112(3):525-32. PubMed ID: 15382081
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.